Date post: | 14-Apr-2018 |
Category: |
Documents |
Upload: | alejandromagno1984 |
View: | 229 times |
Download: | 0 times |
of 52
7/30/2019 EVC Isquemico AHA
1/52
7/30/2019 EVC Isquemico AHA
2/52
Guidelines for the Early Management ofAdults with Ischemic Stroke
From the AHA/ASA Stroke Council
Harold P. Adams, Chair; Gregory del Zoppo, Vice-Chair,Mark J. Alberts, Deepak L Bhatt, Lawrence Brass, Anthony
Furlan, Robert L. Grubb, Randy Higashida, Edward C.
Jauch, Chelsea Kidwell, Patrick D. Lyden, Lewis B.
Morgenstern, Adnan I. Qureshi, Robert H. Rosenwasser,Philip A. Scott, Eelco FM Wijdicks
Stroke 2007; 38(5): 1655-1711
7/30/2019 EVC Isquemico AHA
3/52
Presentation Compiled by theAHA Stroke Council Professional
Education Committee
Susan C. Fagan, Chair
Deborah Bergman
Dawn Bravata
Seemant Chaturvedi
Kari DunningKathryn Taubert, Staff Scientist
Karen Modesitt, Staff
7/30/2019 EVC Isquemico AHA
4/52
Introduction
This slide set was adapted from the AHA/ASAGuidelines for the Early Management of Adults withIschemic Stroke
From the American Heart Association/American
Stroke Association Stroke Council, ClinicalCardiology Council, Cardiovascular Radiology andIntervention Council, and the AtheroscleroticPeripheral Vascular Disease and Quality of CareOutcomes in Research Interdisciplinary WorkingGroups
The American Academy of Neurology affirms thevalue of this guideline as an educational tool forneurologists.
The full-text guidelines are available on the Web site
of the AHA (www.americanheart.org)
http://www.americanheart.org/http://www.americanheart.org/http://www.americanheart.org/7/30/2019 EVC Isquemico AHA
5/52
Introduction Contd
Since the 2003 AHA Stroke Council guidelines,evidence has been published to further refine theapproach to the patient with acute ischemic stroke.
In some cases, where supportive evidence fromclinical trials was not available, the panel made aspecific recommendation on the basispathophysiology and expert practice experience.
7/30/2019 EVC Isquemico AHA
6/52
Changes from 2003 Guidelines
Entirely new section on prehospital care
Stroke Centers
More detailed recommendations on generalsupportive care and hospitalization
Multimodal Imaging
Recommendation to RESTART antihypertensives at24 hours after onset.
New recommendations re: thrombolysis eligibilityand delivery
Adams et al. Stroke 2003; 34:1056-1083
7/30/2019 EVC Isquemico AHA
7/52
Changes from 2003 Guidelines Contd
Recommendations AGAINST clopidogrel acutely
Recommendations AGAINST using experimental
strategies as part of routine care (hyperbaric O2,Merci device, glycoprotein IIbIIIa antagonists, drug-induced hypertension, combination reperfusionstrategies)
Adams et al. Stroke 2003; 34:1056-1083
7/30/2019 EVC Isquemico AHA
8/52
AHA Classes and Levels of Evidence
Class I Agreement the treatment is useful and effective
Class II Conflicting evidence and/or a divergence ofopinion about the usefulness/efficacy of a treatment. Class IIa Weight of evidence is in favor of the
treatment. Class IIb Usefulness/efficacy is less well
established by evidence
Class III Evidence and/or general agreement that thetreatment is not useful/effective and in some cases may be
harmful.
Levels of EvidenceA: Data derived from multiple randomized trials.B: Data derived from a single randomized trial or
nonrandomized studies.C: Consensus opinion of experts.
7/30/2019 EVC Isquemico AHA
9/52
Components of Acute Treatment
Prehospital Care
Stroke Center Designation
Emergency Evaluation and DiagnosticsSupportive Care
Thrombolysis (IV and IA)
Antiplatelet agents / anticoagulants
Volume Expansion / Induced Hypertension
Surgical/ Endovascular Interventions
Combination Reperfusion Therapy
Neuroprotection
Hospital Care
Treatment of Acute Complications
7/30/2019 EVC Isquemico AHA
10/52
Prehospital Management and Field
Treatment
New: Activation of the 9-1-1 systems by patients orother members of the public is strongly supported
because it speeds treatment of stroke (Class I,Level B)
New: To increase the number of patients who canbe seen and treated within the first few hours after
stroke, educational programs to increase publicawareness of stroke are recommended (Class I,Level B)
7/30/2019 EVC Isquemico AHA
11/52
Prehospital Contd
New: To increase the number of patients who aretreated, educational programs for physicians,hospital personnel, and EMS personnel also arerecommended (Class I, Level B)
New : Brief assessment by EMS personnel arerecommended (Class I, Level B)
New :The use of a stroke algorithm is encouraged(Class I, Level B)
7/30/2019 EVC Isquemico AHA
12/52
Prehospital Contd
New: The panel recommends that EMS personnelbegin the initial management of stroke in the field(Class I, Level B)
New : The development of stroke protocols to beused by EMS personnel is strongly encouraged.Patients should be transported rapidly forevaluation and treatment to the closest institution
that provides emergency stroke care as describedin the statement (Class I, Level B)
New: Telemedicine can be an effective method to
extend acute stroke care to rural areas. (Class IIb,Level B)
7/30/2019 EVC Isquemico AHA
13/52
Designation of Stroke Centers
The creation of PSCs is strongly recommended(Class I, Level B). The organization of suchresources will depend on local variable.
The development of CSC is recommended (Class I,Level C)
Certification of stroke centers by an external body,such as JCAHO, is encouraged (Class I, Level B)
For patients with suspected stroke, EMS shouldbypass hospital that do not have resources to treatstroke and got the closest facility capable oftreating acute stroke (Class I Level B)
7/30/2019 EVC Isquemico AHA
14/52
Emergency Diagnosis and Management:Class I recommendations
The goal is to complete an evaluation and decide ontreatment within 60 minutes of the patients arrivalin the ED. Acute stroke teams are encouraged.(Class I, Level B)
The use of a stroke rating scale is recommended(e.g., NIH Stroke Scale) (Class I, Level B)
Patients with clinical evidence of acute cardiac orpulmonary disease may warrant a CXR (Class I,Level B)
7/30/2019 EVC Isquemico AHA
15/52
Emergency Diagnosis and Management
Contd
An ECG is recommended (Class I,Level B)
Basic blood tests are recommended
(Class I, Level B)
7/30/2019 EVC Isquemico AHA
16/52
New: Most patients with acute stroke do not require
a CXR as part of their initial evaluation (Class III,Level B)
Most patients with stroke do not need a CSF exam(consider if clinical picture suggestive of SAH and
CT head normal) (Class III, Level B)
Emergency Diagnosis and Management:
Class III Recommendations
7/30/2019 EVC Isquemico AHA
17/52
Brain and Vascular Imaging : Class Irecommendations
Imaging of the brain is recommended beforeinitiating specific therapy (Class I, Level A)
In most instances, CT will provide the informationto make decisions about emergency management(Class I, Level A)
New: The imaging study should be interpreted by aphysician with expertise in reading brain CT and
MRI(Class I, Level C)
7/30/2019 EVC Isquemico AHA
18/52
Brain and Vascular Imaging: Class Irecommendations
Some findings on CT, such as a dense artery sign,are associated with poor prognosis (Class I, Level
A)
New: Multimodal CT and MRI may provideadditional information that will improve diagnosisof ischemic stroke (Class I, Level A)
7/30/2019 EVC Isquemico AHA
19/52
Brain and Vascular Imaging: Class IIRecommendations
Other than hemorrhage, no specific CT findingshould preclude use of IV rtPA within 3 hours ofstroke onset (Class IIb, Level A)
Vascular imaging is required before intra-arterial orendovascular interventions (Class IIa, Level B)
7/30/2019 EVC Isquemico AHA
20/52
Brain and Vascular Imaging: Class IIIRecommendations
New: Emergency treatment of stroke should not bedelayed in order to obtain multimodal imaging
studies (Class III, Level C)
New: Vascular imaging studies should not delaytreatment of acute stroke patients whose symptomsstarted
7/30/2019 EVC Isquemico AHA
21/52
General Supportive Care: Class IRecommendations
Airway support and ventilatory assistance arerecommended for the treatment of acute stroke(Class I, Level C)
Hypoxic patients with stroke should receivesupplemental oxygen (Class I, Level C)
Fever should be treated and antipyretic medicationsshould administered to lower temperature in febrile
patients (Class I, Level C)
7/30/2019 EVC Isquemico AHA
22/52
General Supportive Care Contd
Cardiac monitoring to screen for atrial fibrillationand other potentially serious cardiac arrhythmiasshould be performed during the first 24 hours after
onset of ischemic stroke (Class I Level B)
The management of arterial hypertension remainscontroversial. It is generally agreed that a cautiousapproach to the treatment of arterial hypertension
should be recommended (Class I, Level C)
7/30/2019 EVC Isquemico AHA
23/52
General Supportive Care Contd
Patients who have elevated blood pressure and areotherwise eligible for treatment of rtPA may havetheir blood pressure lowered so that their systolicis< 185 mm Hg and their diastolic blood pressure is< 110 mm Hg (Class I, Level B)
New: Until other data become available, consensusexists that the previously described blood pressurerecommendations should be followed in patients
undergoing other acute interventions to recanalizeoccluded vessels, including intra-arterialthrombolysis (Class I, Level C)
7/30/2019 EVC Isquemico AHA
24/52
General Supportive Care Contd
New : Patients with markedly elevated bloodpressure may have their blood pressure lowered. Areasonable goal is ~ 15% during the first 24 hoursafter onset of stroke. Medications should be
withheld unless SPB > 220 or MAP >120 (Class I,Level C)
The cause of arterial hypotension in the setting ofacute stroke should be sought (Class I, Level C)
New: Hypoglycemia should be treated in patientswith acute ischemic stroke (Class I, Level C).Marked elevations in blood glucose should beavoided.
7/30/2019 EVC Isquemico AHA
25/52
General Supportive Care: Class IIRecommendations
New: There is no data to guide selection ofmedications for the lowering of blood pressure inthe setting of acute ischemic stroke. Therecommended medications and doses are based on
general consensus (Class IIa, Level C)
New: For patients with preexisting hypertensionevidence indicates antihypertensive therapymedications should be restarted at ~ 24 hours(Class IIa, Level B)
New: Persistent hyperglycemia (>140 mg/dL) duringthe first 24 hours after stroke is associated withpoor outcomes (Class IIa, Level C)
7/30/2019 EVC Isquemico AHA
26/52
General Supportive Care: Class IIIRecommendations
Non-hypoxic patients with acute ischemic stroke donot need supplemental oxygen therapy (Class III,Level B
New: Data on hyperbaric oxygen are inconclusive,and some data imply that the intervention may beharmful (Class III, Level B)
Despite the efficacy of hypothermia for improving
neurological outcomes after cardiac arrest, theutility of induced hypothermia for the treatment ofpatients with acute ischemic stroke is notestablished (Class III, Level B)
7/30/2019 EVC Isquemico AHA
27/52
Intravenous Thrombolysis: Class I
Recommendations
IV rtPA (0.9 mg.kg, maximum dose 90 mg) isrecommended for selected patients who may be
treated within 3 hours of onset of ischemic stroke(Class I, Level A)
New: Besides bleeding complications, physiciansshould be aware of the potential side effect of
angioedema that may cause partial airwayobstruction (Class I, Level C)
7/30/2019 EVC Isquemico AHA
28/52
Intravenous Thrombolysis: Class IIRecommendations
A patient whose BP can be safely lowered withantihypertensive agents may be eligible fortreatment. (Class IIa, Level B)
New: A patient with a seizure at the time of onsetmay be eligible for treatment. (Class IIa, Level C)
7/30/2019 EVC Isquemico AHA
29/52
Intravenous Thrombolysis: Class IIIRecommendations
IV streptokinase for treatment of stroke IS NOTrecommended. (Class III, Level A)
New: Use of IV fibrinolytics other than tPA(reteplase, tenecteplase, etc) outside a clinical trialin NOT recommended. (Class III, Level C)
7/30/2019 EVC Isquemico AHA
30/52
Intraarterial Thrombolysis: Class IRecommendations
Intraarterial thrombolysis is an option for majorstroke if administered within 6 hours of onset.( Class I, Level B)
Intraarterial thrombolysis should only be attemptedat experienced stroke centers (Class I, Level C)
7/30/2019 EVC Isquemico AHA
31/52
Intra-Arterial Thrombolysis : Class IIIII recommendations
New: Intra-arterial thrombolysis is reasonable inpatients who have contraindications to use of IVthrombolysis, such as recent surgery (Class II, LvelC)
The availability of intra-arterial thrombolysis shouldgenerally NOTpreclude the use of IV rtPA in eligiblepatients (Class III, Level C)
7/30/2019 EVC Isquemico AHA
32/52
Combination Reperfusion Therapies :Class III recommendation
New: Combinations of interventions to restoreperfusion cannot be recommended outside thesetting of clinical trials (Class III, Level B)
7/30/2019 EVC Isquemico AHA
33/52
Anticoagulation: Class IIIRecommendations
Urgent anticoagulation for the prevention of earlyrecurrence, halting worsening or improvingoutcomes, is NOT recommended. (Class III, Level A)
Urgent anticoagulation is NOT recommended formoderate to severe strokes because of anincreased risk of serious intracranial hemorrhage.(Class III, Level A)
Initiation of anticoagulant therapy within 24 h of IVrtPA is NOT recommended. (Class III, Level B)
7/30/2019 EVC Isquemico AHA
34/52
AntiplateletTherapy: Class I Recommendation
New Dose Added: Oral aspirin (initial dose of 325mg) within 24 to 48 hours of stroke onset is
recommended for most patients (Class I, Level A)
7/30/2019 EVC Isquemico AHA
35/52
Antiplatelet Therapy: Class IIIRecommendations
Aspirin should NOT be considered a substitute forIV rtPA. (Class III, Level A)
Aspirin is NOT recommended within 24 h of IV rtPA.(Class III, Level A)
New: Clopidogrel alone or in combination with
aspirin is NOT recommended. (Class III, Level C)
New: Use of IV GPIIbIIIa receptor antagonistsoutside of clinical trials NOT recommended. (ClassIII, Level B)
7/30/2019 EVC Isquemico AHA
36/52
Hemodilution : Class IIIRecommendation
Hemodilution with or without volume expansion isNOT recommended for patients with acuteischemic stroke (Class III, Level A)
7/30/2019 EVC Isquemico AHA
37/52
Vasodilators in Acute Ischemic Stroke
Methylxanthine derivatives (e.g., pentoxifylline) arevasodilators that also inhibit platelet aggregation
Several studies have evaluated the use ofpentoxifylline for the reduction of 30-day mortality
Neither pentoxifylline nor pentofylline has beenshown to improve outcomes after stroke
7/30/2019 EVC Isquemico AHA
38/52
Vasodilators: Class III Recommendation
Medications such as pentoxifylline are NOT
recommended for patients with acute ischemicstroke (Class III, Level A)
7/30/2019 EVC Isquemico AHA
39/52
Induced Hypertension Recommendations
Class I: New: In exceptional cases, vasopressors may be
used to improve cerebral blood flow, but this use
requires close neurological and cardiac monitoring(Class I, Level C)
Class III: New: Drug-induced hypertension is NOT
recommended for most patients with acuteischemic stroke (Class III, Level B)
7/30/2019 EVC Isquemico AHA
40/52
No Surgical Recommendations
Safety and effectiveness data about surgicalinterventions for patients with acute ischemicstroke are insufficient to make recommendations
7/30/2019 EVC Isquemico AHA
41/52
Endovascular Intervention : Class IIRecommendations
New: Although the MERCI device is a reasonableintervention for extraction of intra-arterial thrombiin carefully selected patients, the utility of thedevice in improving outcomes after stroke is
unclear; additional clinical trials are needed todefine its role in the emergency management ofstroke (Class IIb, Level B)
The usefulness of other endovascular treatments isnot established(Class IIb, Level C)
7/30/2019 EVC Isquemico AHA
42/52
Neuroprotection: Class IIIRecommendation
NO intervention with putative neuroprotectiveactions has been established as effective inimproving outcomes after stroke, and therefore
none currently can be recommended (Class III,Level A)
7/30/2019 EVC Isquemico AHA
43/52
Hospitalization: Class IRecommendations
The use of stroke units incorporating rehabilitationis recommended (Class I, Level A)
SC anticoagulants for prevention of DVT inimmobilized patients is recommended (Class I,Level A)
New: The use of standardized stroke care ordersets in recommended (Class I, Level B)
Early mobilization to prevent subacute
complications of stroke is recommended (Class I,Level C)
7/30/2019 EVC Isquemico AHA
44/52
Hospitalization: Class IRecommendations
New: Assessment of swallowing before startingeating or drinking is recommended (Class I, Level B)
Patients with pneumonia or UTI should receiveantibiotics (Class I, Level B).
Treatment of concomitant medical diseases isrecommended (Class I, Level C)
Early institution of interventions to prevent recurrentstroke is recommended (Class I, Level C)
7/30/2019 EVC Isquemico AHA
45/52
Hospitalization: Class IIRecommendations
New: Patients who cannot take food and fluidsorally should receive NG, ND or PEG feedings tomaintain hydration and nutrition while undergoingefforts to restore swallowing (Class IIa, Level B)
ASA can be used for DVT prophylaxis but is lesseffective than anticoagulation (Class IIa, Level A)
Intermittent pneumatic compression devices arerecommended for patients who cannot receiveanticoagulation (Class IIa, Level B)
7/30/2019 EVC Isquemico AHA
46/52
Hospitalization: Class IIIRecommendations
New: Nutritional supplements are NOT needed(Class III, Level B)
New: Prophylactic antibiotics are NOTrecommended (Class III, Level B)
If possible, placement of an indwelling bladdercatheter should be avoided because of risk of UTI
(Class III, Level C)
7/30/2019 EVC Isquemico AHA
47/52
Treatment of Neurologic Complications :Class I Recommendations
Patients with major infarctions affecting thecerebral hemisphere or cerebellum are at high riskof brain edema and increased ICP. Measures tolessen the risk of edema and close monitoring ofthe patient for worsening during the first days arerecommended (Class I, Level B) New: Transfer ofthe patient to a center with neurosurgical expertiseshould be considered
Patients with acute hydrocephalus secondary toischemic stroke can be treated with a ventriculardrain (Class I, Level B)
7/30/2019 EVC Isquemico AHA
48/52
Treatment of Neurologic Complications :Class I Recommendations
Decompressive surgical evacuation of a space-occupying cerebellar infarction is a potentially life-
saving measure, and clinical recovery may be verygood (Class I, Level B)
Recurrent seizures after stroke should be treated aswith other acute neurological conditions (Class I,
Level B)
7/30/2019 EVC Isquemico AHA
49/52
Treatment of Neurologic Complications :Class II Recommendations
Aggressive medical measures, includingosmotherapy, are UNPROVEN for management ofmalignant ischemic cerebral edema (Class IIa, Level
C). Hyperventilation is short-lived and medicalmeasures could delay decompressive surgery.
Decompressive surgery for malignant edema in thecerebral hemisphere may be lifesaving but impacton morbidity is unknown. For severely afflicted
patients, advice about the possibility of life withsevere disability should be given to the family(Class IIa, Level B)
7/30/2019 EVC Isquemico AHA
50/52
Treatment of Neurologic Complications :Class II Recommendations
New: No specific recommendation is made fortreatment of asymptomatic hemorrhagictransformation (Class IIb, Level C)
7/30/2019 EVC Isquemico AHA
51/52
Treatment of Neurologic Complications:Class III Recommendations
Corticosteroids NOT recommended (Class III, LevelA)
Prophylactic anticonvulsants are NOTrecommended (Class III, Level C)
7/30/2019 EVC Isquemico AHA
52/52
Summary
These guidelines provide comprehensive andtimely evidence-based recommendations.
There is an intent to fully update the guidelinesevery three years, with updates encouraged whenpivotal studies are published.